Content TV

+

PFO closure with Amplatzer™ Talisman™ PFO Occluder in patients >60 years

An analysis was performed on real-world outcomes of U.S. Medicare beneficiaries >60 years old with presumed PFO-associated stroke implanted with the Amplatzer™ PFO Occluder or the Amplatzer™ Talisman™ PFO Occluder.

Download

Related Resources

TRENDING TOPICS

Novel approaches for Valvular and LVAD therapies

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Cleveland Clinic’s Porcine vs. Bovine Outcomes

Early outcomes on Epic Max platfrom

Cleveland Clinic’s Porcine vs. Bovine Outcomes

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Transfemoral TAVI

Transfemoral TAVI

Transfemoral TAVI

Navitor Vision 35 implantation

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline